Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Open Access Maced J Med Sci ; 6(9): 1647-1651, 2018 Sep 25.
Artigo em Inglês | MEDLINE | ID: mdl-30337981

RESUMO

BACKGROUND: Radical cystectomy is the standard treatment for nonmetastatic bladder cancer (muscle-invasive and selective superficial bladder cancer). There are many types of urinary diversion after this procedure; the ileal conduit is the most and simplest one. AIM: To asses clinical, pathological profile, early complication, functional and oncological outcome after radical cystectomy and ileal conduit for muscle-invasive bladder cancer patients. METHOD: Between January 2013 and December 2016, there were 68 patients diagnosed with bladder cancer. From those patients, 24 (35.29%) patients had been performed radical cystectomy with ileal conduit type for urinary diversion (100%). Patients demographic, clinical and pathological profile, early postoperative complication, functional and oncological outcome were collected from the medical record. RESULT: Among the 24 patients who underwent radical cystectomy, 20 patients were male (83.3%) with the mean age was 57.3 y.o (33-77 y.o). Twelve patients (50%) showed pT4 and pT2 respectively. Based on pathological result 20 patient (83.34%) had the urothelial carcinoma, three patients (12.5%) had squamous cell carcinoma, and one patient (4.1%) had adenocarcinoma. Two patients (8.3%) got neoadjuvant chemotherapy, and nine patient (37.5%) of patients followed adjuvant chemotherapy after surgery. Wound dehiscence, fistula enterocutan, prolong ileus, leakage anastomosis and sepsis were kind of complication after surgery. One year's survival rate is 84%, mortality rate 20.8% and a recurrence rate of 20.8% in 4 years follow up. CONCLUSION: Radical cystectomy and ileal conduit type of urinary diversion still become the preferable procedure for nonmetastatic bladder cancer with good functional and oncological outcome.

2.
Neurology Asia ; : 171-174, 2009.
Artigo em Inglês | WPRIM (Pacífico Ocidental) | ID: wpr-628879

RESUMO

Solitary osseous plasmacytoma of the orbit is very rare. It can be part of generalized disease (multiple myeloma) or as localized disease, presenting as orbital tumor. We report a case of solitary osseous plasmacytoma of the orbit with multiple myeloma. This 43-year old male presented with 6 months history of proptosis and decreased visual acuity. CT scan showed an osteolytic, well demarcated lesion with homogenous contrast enhancement in the superolateral part of the right orbit. The tumor including the osteolytic lesion was totally removed. The pathological report revealed a plasmacytoma. Further investigation showed that the plasmacytoma was part of generalized multiple myeloma. The patient was treated with radiation and combination chemotherapy postoperatively. Twenty months after surgery, the local tumor remained well controlled. However, there was systemic progression of the disease, with multiple cutaneous mass and pleural effusion. These resulted in the patient’s deterioration and fi nal demise.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...